These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 1549027)
1. Extrinsic plasminogen activator response to exercise after a single dose of propranolol. el-Sayed MS Med Sci Sports Exerc; 1992 Mar; 24(3):327-32. PubMed ID: 1549027 [TBL] [Abstract][Full Text] [Related]
2. Effect of two formulations of a beta blocker on fibrinolytic response to maximum exercise. el-Sayed MS; Davies B Med Sci Sports Exerc; 1989 Aug; 21(4):369-73. PubMed ID: 2571061 [TBL] [Abstract][Full Text] [Related]
3. Exercise intensity-related responses of fibrinolytic activity and vasopressin in man. el-Sayed MS Med Sci Sports Exerc; 1990 Aug; 22(4):494-500. PubMed ID: 2402210 [TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic and hemostatic parameter response after resistance exercise. el-Sayed MS Med Sci Sports Exerc; 1993 May; 25(5):597-602. PubMed ID: 8492688 [TBL] [Abstract][Full Text] [Related]
5. Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human blood. Kluft C; Jie AF; Allen RA Thromb Haemost; 1983 Aug; 50(2):518-23. PubMed ID: 6356452 [TBL] [Abstract][Full Text] [Related]
6. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma. Dooijewaard G; de Boer A; Turion PN; Cohen AF; Breimer DD; Kluft C Thromb Haemost; 1991 Jan; 65(1):82-6. PubMed ID: 1902597 [TBL] [Abstract][Full Text] [Related]
7. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia]. Astedt B; Fagner U Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913 [TBL] [Abstract][Full Text] [Related]
8. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers. Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009 [TBL] [Abstract][Full Text] [Related]
10. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. Rijken DC; Juhan-Vague I; de Cock F; Collen D J Lab Clin Med; 1983 Feb; 101(2):274-84. PubMed ID: 6681623 [TBL] [Abstract][Full Text] [Related]
11. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. van Giezen JJ; Boon GI; Jansen JW; Bouma BN Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851 [TBL] [Abstract][Full Text] [Related]
12. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator. Watahiki Y; Scully MF; Ellis V; Kakkar VV Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259 [TBL] [Abstract][Full Text] [Related]
13. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential. Onundarson PT; Francis CW; Marder VJ J Lab Clin Med; 1992 Jul; 120(1):120-8. PubMed ID: 1613318 [TBL] [Abstract][Full Text] [Related]
14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
15. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Sabovic M; Lijnen HR; Keber D; Collen D Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays. Camiolo SM; Greco WR Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257 [TBL] [Abstract][Full Text] [Related]
17. Effects of diltiazem or propranolol during exercise training of hypertensive men. Stewart KJ; Effron MB; Valenti SA; Kelemen MH Med Sci Sports Exerc; 1990 Apr; 22(2):171-7. PubMed ID: 2355813 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA]. Ieko M Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966 [TBL] [Abstract][Full Text] [Related]
19. [The relation between myocardial oxygen consumption and ischemia during exertion in patients with angina pectoris: effect of propranolol]. Galvani M; Bugiardini R; Ferrini D; Gridelli C; Mari L; Pozzati A; Ferramosca B; Puddu P G Ital Cardiol; 1985 Nov; 15(11):1032-8. PubMed ID: 3007250 [TBL] [Abstract][Full Text] [Related]
20. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise. Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]